About this trial
A non-invasive modality for the management of neuromusculoskeletal pain conditions that has emerged as a compelling option is high-power laser therapy (HPLT). The pathophysiology of notalgia paresthetica (NP) is treated uniquely by HPLT, which targets both the presumed muscular component of nerve entrapment and the resultant neuropathic symptoms. The main goal of this study, which is randomised, controlled and blinded by assessors, is to find out how well High-Power Laser Therapy (HPLT) works as an extra treatment to standard care in reducing itching, pain and improving quality of life for patients with long-term nerve pain.
Eligibility criteria
Qualifiers
Adults aged 18-75 years
Clinical diagnosis of unilateral Notalgia Paresthetica for at least 3 months
Presence of characteristic symptoms (pruritus, paresthesia, and/or burning pain) in the typical T2-T6 dermatomal distribution
A minimum score of 4 on the Numeric Rating Scale (NRS) for pruritus intensity
Disqualifiers
- Secondary causes of symptoms (e.g., spinal pathology, herpes zoster, renal failure)
Previous spinal surgery in the thoracic region
Coagulopathy or use of anticoagulant medication
Skin diseases or infections in the treatment area
Trial design
Treatments tested in this trial
- High-power laser
- Sham Laser
Treatment groups
Locations
Sponsors and collaborators
Uşak University
Lead sponsor
Balikesir University
Collaborator